Drug Profile
Triiodothyronine implant - Titan Pharmaceuticals
Alternative Names: L-T3 implant - Titan Pharmaceuticals; T3 implant - Titan PharmaceuticalsLatest Information Update: 29 Aug 2023
Price :
$50
*
At a glance
- Originator Titan Pharmaceuticals
- Class Amino acids; Small molecules; Thyronines
- Mechanism of Action Thyroid hormone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Hypothyroidism
Most Recent Events
- 29 Aug 2023 Discontinued - Preclinical for Hypothyroidism in USA (SC) (Titan Pharmaceuticals pipeline, August 2023)
- 28 Feb 2021 No recent reports of development identified for preclinical development in Hypothyroidism in USA (SC, Implant)
- 23 Jan 2017 Preclinical trials in Hypothyroidism in USA (SC) (Titan Pharmaceuticals pipeline, January 2017)